DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway

BACKGROUND: Disabled homolog 2 interacting protein (DAB2IP) plays a tumor-suppressive role in several types of human cancers. However, the molecular status and function of the DAB2IP gene in esophageal squamous cell carcinoma (ESCC) patients who received definitive chemoradiotherapy is rarely report...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Zhuting, Fang, Weiyang, Xu, Meng, Xia, YeYe, Wang, Rui, Li, Yue, Zha, Tianqi, Xiao, Liang, Pan, Shuhao, Chai, Huiping, Zhao, Lei, Wang, Hao, Pan, Huaguang, Chen, Xiangcun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897861/
https://www.ncbi.nlm.nih.gov/pubmed/35248066
http://dx.doi.org/10.1186/s12935-022-02535-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897861/
https://www.ncbi.nlm.nih.gov/pubmed/35248066
http://dx.doi.org/10.1186/s12935-022-02535-9

Ejemplares similares